Literature DB >> 15349132

The management of fibromyalgia.

Srinivas G Rao1, Daniel J Clauw.   

Abstract

Fibromyalgia is one of a number of overlapping "functional somatic syndromes", including irritable bowel syndrome, tension headache, chronic idiopathic lower back pain, chronic fatigue syndrome and others. These conditions affect females more frequently than males and probably share common underlying neurobiological mechanisms, as well as frequent psychological, cognitive and behavioral comorbidities. Since the pain in these conditions is most likely "central" in origin, classes of drugs such as nonsteroidal antiinflammatory drugs (NSAIDs) and opioids, which are quite effective for "peripheral" pain, are relatively ineffective for the pain seen in these syndromes. Instead, tricyclic and other classes of antidepressants, antiseizure drugs and a number of other neuroactive compounds seem to be more effective. In addition, nonpharmacological therapies such as aerobic exercise and cognitive behavioral therapy are quite effective and frequently underutilized in clinical practice. Copyright 2004 Prous Science

Entities:  

Mesh:

Year:  2004        PMID: 15349132     DOI: 10.1358/dot.2004.40.6.850485

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  10 in total

Review 1.  Opioids for managing chronic non-malignant pain: safe and effective prescribing.

Authors:  Meldon Kahan; Anita Srivastava; Lynn Wilson; Angela Mailis-Gagnon; Deana Midmer
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

2.  2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; Don L Goldenberg; John X Pereira; Susan Abbey; Manon Choinière; Gordon Ko; Dwight E Moulin; Pantelis Panopalis; Johanne Proulx; Yoram Shir
Journal:  Pain Res Manag       Date:  2013 May-Jun       Impact factor: 3.037

3.  Fibromyalgia and myofascial pain syndrome-a dilemma.

Authors:  H C Chandola; Arunangshu Chakraborty
Journal:  Indian J Anaesth       Date:  2009-10

4.  New and emerging therapeutic agents for the treatment of fibromyalgia: an update.

Authors:  Jill M Recla
Journal:  J Pain Res       Date:  2010-07-22       Impact factor: 3.133

5.  Antidepressants in the treatment of fibromyalgia.

Authors:  Chantal Moret; Mike Briley
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

Review 6.  Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology.

Authors:  Sanam Kia; Ernet Choy
Journal:  Biomedicines       Date:  2017-05-08

7.  LPA1 receptor involvement in fibromyalgia-like pain induced by intermittent psychological stress, empathy.

Authors:  Hiroshi Ueda; Hiroyuki Neyama
Journal:  Neurobiol Pain       Date:  2017-04-17

8.  Low-Dose Dextromethorphan for the Treatment of Fibromyalgia Pain: Results from a Longitudinal, Single-Blind, Placebo-Controlled Pilot Trial.

Authors:  Christina Mueller; Timothy J Ness; Jarred W Younger
Journal:  J Pain Res       Date:  2021-01-27       Impact factor: 3.133

9.  Treatment options and patient perspectives in the management of fibromyalgia: future trends.

Authors:  Kim Lawson
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

10.  Characteristics and healthcare costs of patients with fibromyalgia syndrome.

Authors:  A Berger; E Dukes; S Martin; J Edelsberg; G Oster
Journal:  Int J Clin Pract       Date:  2007-07-26       Impact factor: 2.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.